Please Wait.....
Report
Australia and New Zealand Healthcare CROs Market Report and Forecast 2024-2032
Market Report I 2023-09-16 I 140 Pages I EMR Inc.
Australia and New Zealand Healthcare CROs Market Report and Forecast 2024-2032
Australia and New Zealand Healthcare CROs Market Outlook
The Australia and New Zealand healthcare CROs market size was valued USD 1.1 billion in 2023, driven by increasing complexity of clinical trials, rising R&D costs, the need for specialized expertise, and the focus on accelerating drug development. The market size is anticipated to grow at a CAGR of 11.9% during the forecast period of 2024-2032 to achieve a value of USD 3.0 billion by 2032.
Australia and New Zealand Healthcare CROs: Introduction
The healthcare Contract Research Organizations (CROs) market in Australia and New Zealand refers to the segment of the clinical research industry that provides outsourced services to pharmaceutical, biotechnology, and medical device companies in these countries. CROs play a crucial role in conducting clinical trials and providing various research and development services to support the development of new drugs, therapies, and medical devices.
Healthcare CROs in Australia and New Zealand offer a wide range of services to support the entire clinical trial process. These services include protocol development, site selection and management, patient recruitment, data management and analysis, regulatory submissions, safety monitoring, and quality assurance. CROs assist in streamlining the clinical trial process, ensuring compliance with regulatory requirements, and providing expertise and resources to efficiently conduct trials.
Key Trends in the Australia and New Zealand Healthcare CROs Market
Key Trends in the Australia and New Zealand healthcare CROs market:
- Increasing Outsourcing of Clinical Research: Pharmaceutical and biotechnology companies in Australia and New Zealand are increasingly outsourcing their clinical research activities to CROs. This trend is driven by the need for specialized expertise, cost-efficiency, and the ability to access a global network of investigators and patients.
- Growing Demand for Oncology Trials: Oncology clinical trials have witnessed significant growth in Australia and New Zealand. There is a rising demand for CROs specializing in oncology research due to the increasing prevalence of cancer and advancements in personalized medicine.
- Emphasis on Patient-Centric Approach: There is a growing emphasis on patient-centricity in clinical trials, and CROs are adopting strategies to enhance patient recruitment, engagement, and retention. CROs are leveraging technology, such as mobile applications and virtual visits, to improve patient experience and reduce the burden of participation.
- Digital Transformation and Data Analytics: The healthcare CROs market is undergoing digital transformation, with the adoption of technologies like electronic data capture (EDC), electronic patient-reported outcomes (ePRO), wearables, and data analytics. These technologies enable real-time data collection, remote monitoring, and advanced analytics, enhancing the efficiency and accuracy of clinical trials.
- Regulatory Compliance and Quality Assurance: The regulatory landscape for clinical trials is evolving, necessitating CROs to ensure compliance with stringent regulatory requirements. CROs in Australia and New Zealand are focusing on quality assurance and implementing robust systems and processes to maintain compliance with regulatory guidelines.
Australia and New Zealand Healthcare CROs Market Segmentation
The market can be categorised into phase type, and indication.
Market Breakup by Phase Type
- Drug Discovery
- Preclinical
- Clinical
Market Breakup by Indication
- Oncology
- Cardiovascular
- Autoimmune/Inflammation
- Central Nervous System (CNS)
- Dermatology
- Infectious Diseases
- Respiratory
- Others
Australia and New Zealand Healthcare CROs Market Overview
The healthcare CROs market in Australia and New Zealand has experienced significant growth in recent years. Factors contributing to market growth include the increasing complexity of clinical trials, rising R&D costs, the need for specialized expertise, and the focus on accelerating drug development.
The healthcare CROs market in Australia and New Zealand is competitive, with both local and international players operating in the region. Key market players include large multinational CROs, mid-size CROs, and niche specialty CROs. These CROs compete based on their therapeutic expertise, quality of services, geographical reach, and technological capabilities. The healthcare CROs market in Australia and New Zealand is expected to continue growing in the coming years. Factors such as the increasing focus on personalized medicine, advancements in digital health technologies, the need for efficient drug development processes, and the growing demand for real-world evidence (RWE) are expected to drive market growth. CROs that can adapt.
Key Players in the Australia and New Zealand Healthcare CROs Market
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in Australia and New Zealand healthcare CROs market are as follows:
- PAREXEL International Corporation
- Thermo SGS SA
- ICON plc
- Medpace Australia Pty. Ltd
- Charles River Laboratories International, Inc.
- IQVIA
- Novotech
- Laboratory Corporation of America Holdings
- Syneos Health
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1Preface
1.1Objectives of the Study
1.2Key Assumptions
1.3Report Coverage - Key Segmentation and Scope
1.4Research Methodology
2Executive Summary
3Australia and New Zealand Healthcare CROs Market Overview
3.1Australia and New Zealand Healthcare CROs Market Historical Value (2017-2023)
3.2Australia and New Zealand Healthcare CROs Market Forecast Value (2024-2032)
4Australia and New Zealand Healthcare CROs Market Landscape
4.1Lentiviral Vectors: Developers Landscape
4.1.1Analysis by Year of Establishment
4.1.2Analysis by Company Size
4.1.3Analysis by Region
4.2Lentiviral Vectors: Product Landscape
4.2.1Analysis by Type
4.2.2Analysis by Applications
5Australia and New Zealand Healthcare CROs Market Dynamics
5.1Market Drivers and Constraints
5.2SWOT Analysis
5.3Porter's Five Forces Model
5.4Key Demand Indicators
5.5Key Price Indicators
5.6Industry Events, Initiatives, and Trends
5.7Value Chain Analysis
6Australia and New Zealand Healthcare CROs Market Segmentation
6.1Australia and New Zealand Healthcare CROs Market by Phase Type
6.1.1Market Overview
6.1.2Drug Discovery
6.1.3Preclinical
6.1.4Clinical
6.2Australia and New Zealand Healthcare CROs Market by Indication
6.2.1Market Overview
6.2.2Oncology
6.2.3Cardiovascular
6.2.4Autoimmune/Inflammation
6.2.5Central Nervous System (CNS)
6.2.6Dermatology
6.2.7Infectious Diseases
6.2.8Respiratory
6.2.9Others
7Australia and New Zealand Healthcare CROs Market
7.1Market Share by Country
7.2Australia
7.3New Zealand
8Funding and Investment Analysis
8.1Analysis by Funding Instances
8.2Analysis by Type of Funding
8.3Analysis by Funding Amount
8.4Analysis by Leading Players
8.5Analysis by Leading Investors
8.6Analysis by Geography
9Partnership and Collaborations Analysis
9.1Analysis by Partnership Instances
9.2Analysis by Type of Partnership
9.3Analysis by Leading Players
9.4Analysis by Geography
10Supplier Landscape
10.1PAREXEL International Corporation
10.1.1Financial Analysis
10.1.2Product Portfolio
10.1.3Demographic Reach and Achievements
10.1.4Mergers and Acquisitions
10.1.5Certifications
10.2Thermo Fischer Scientific, Inc.
10.2.1Financial Analysis
10.2.2Product Portfolio
10.2.3Demographic Reach and Achievements
10.2.4Mergers and Acquisitions
10.2.5Certifications
10.3SGS SA
10.3.1Financial Analysis
10.3.2Product Portfolio
10.3.3Demographic Reach and Achievements
10.3.4Mergers and Acquisitions
10.3.5Certifications
10.4ICON plc
10.4.1Financial Analysis
10.4.2Product Portfolio
10.4.3Demographic Reach and Achievements
10.4.4Mergers and Acquisitions
10.4.5Certifications
10.5Medpace Australia Pty. Ltd
10.5.1Financial Analysis
10.5.2Product Portfolio
10.5.3Demographic Reach and Achievements
10.5.4Mergers and Acquisitions
10.5.5Certifications
10.6Charles River Laboratories International, Inc.
10.6.1Financial Analysis
10.6.2Product Portfolio
10.6.3Demographic Reach and Achievements
10.6.4Mergers and Acquisitions
10.6.5Certifications
10.7IQVIA
10.7.1Financial Analysis
10.7.2Product Portfolio
10.7.3Demographic Reach and Achievements
10.7.4Mergers and Acquisitions
10.7.5Certifications
10.8Novotech
10.8.1Financial Analysis
10.8.2Product Portfolio
10.8.3Demographic Reach and Achievements
10.8.4Mergers and Acquisitions
10.8.5Certifications
10.9Laboratory Corporation of America Holdings
10.9.1Financial Analysis
10.9.2Product Portfolio
10.9.3Demographic Reach and Achievements
10.9.4Mergers and Acquisitions
10.9.5Certifications
10.10Syneos Health
10.10.1Financial Analysis
10.10.2Product Portfolio
10.10.3Demographic Reach and Achievements
10.10.4Mergers and Acquisitions
10.10.5Certifications
11Key Opinion Leaders (KOL) Insights (Additional Insight)
12Company Competitiveness Analysis (Additional Insight)
12.1Very Small Companies
12.2Small Companies
12.3Mid-Sized Companies
12.4Large Companies
12.5Very Large Companies
13Payment Methods (Additional Insight)
13.1Government Funded
13.2Private Insurance
13.3Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security